GC Cell
Blood & Organ Banks · South Korea · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
107 Ihyeon-ro 30beon-gil, Giheung-gu Yon...Phone Number
+82 221010600Website
www.gccell.comRevenue
$137.8 MillionIndustry
About GC Cell
GC Cell Org Chart
Is GC Cell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if GC Cell had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at GC Cell
GC Cell, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if GC Cell is spiking on competitors!
Earning: See what the market has to say on GC Cell recently announced quarterly report
Funding: Get notified immidiatlly once GC Cell has new funding data
Product Launch: Get notified when GC Cell launches new products
Check if GC Cell has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at GC Cell
Find 3 more new buyers
Company Profile Activity
Activity Insights
GC Cell is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
GC Cell is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about GC Cell.
GC Cell Tech Stack
A closer look at the technologies used by GC Cell
GC Cell News & Media
DAAN Biotherapeutics and GC Cell Sign Exclusive Technology Transfer Agreement for Tumor Antigen-Specific Antibody Sequence to Advance CAR-T and CAR-NK Cell Therapies
SEOUL, South Korea, April 21, 2025 /PRNewswire/ -- DAAN Biotherapeutics, a leading innovative drug development company specializing in T-Cell receptor (TCR)-based therapies, has signed an exclusive licensing agreement with GC Cell, a gene and cell therapy firm, for the tumor...GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T‑Cell Lymphoma CD5 CAR-NK Therapy
YONGIN, South Korea, March 12, 2025 /PRNewswire/ -- GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB‑205), a novel CD5 CAR‑NK cell therapy. This "first patient dosing" marks a critical...GC Cell Symposium with Bifarma Expands Global Impact and Reach for Immuncell-LC
YONGIN, South Korea, Jan. 22, 2025 /PRNewswire/ -- GC Cell, a leading cell and gene therapy company, announced the successful completion of its first thought leadership symposium in Jakarta, Indonesia. The event was organized in collaboration with PT Bifarma Adiluhung (Bifarma), a pioneer...GC Cell and PT Bifarma Adiluhung sign a licensing agreement for Immuncell-LC to expand access in Indonesia
YONGIN, South Korea, Sept. 11, 2024 /PRNewswire/ -- GC Cell, a leading innovator in cell therapy, has officially announced the execution of a landmark 'Technology Transfer and License Agreement' with PT Bifarma Adiluhung (Bifarma), a premier stem cell therapy company in Indonesia. This strategic partnership, which began in June, solidifies approximately three months later with the signing of the final license agreement. GC Cell and PT Bifarma Adiluhung sign a licensing agreement for Immuncell-LC
Top Blood & Organ Banks Companies
Frequently Asked Questions Regarding GC Cell
GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. Its main product is Immuncell-LC. GC Cell Corporation has strategic agreement with Lukas Biomedical Co., Ltd. to develop Cell therapy. The company was formerly known as Green Cross Lab Cell Corporation an... Read More